Baseline lncRNA PCAT1 high expression and its longitude increment during induction therapy predict worse prognosis in multiple myeloma patients

BACKGROUND: Long noncoding RNA PCAT1 (lnc‐PCAT1) involves in the proliferation and drug sensitivity of multiple myeloma (MM), while its prognostic role in MM patients is still obscure. This study aimed to explore the association of lnc‐PCAT1 with MM risk, clinical characteristics, treatment response...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Peng, Zhao, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605116/
https://www.ncbi.nlm.nih.gov/pubmed/34564896
http://dx.doi.org/10.1002/jcla.23924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605116/
https://www.ncbi.nlm.nih.gov/pubmed/34564896
http://dx.doi.org/10.1002/jcla.23924

Ejemplares similares